Barinthus Biotherapeutics PLC banner

Barinthus Biotherapeutics PLC
NASDAQ:BRNS

Watchlist Manager
Barinthus Biotherapeutics PLC Logo
Barinthus Biotherapeutics PLC
NASDAQ:BRNS
Watchlist
Price: 0.61 USD 1.67% Market Closed
Market Cap: $24.9m

Intrinsic Value

The intrinsic value of one BRNS stock under the Base Case scenario is 1.66 USD. Compared to the current market price of 0.61 USD, Barinthus Biotherapeutics PLC is Undervalued by 63%.

BRNS Intrinsic Value
1.66 USD
Undervaluation 63%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Barinthus Biotherapeutics PLC

What is Valuation History?
Ask AI Assistant
What other research platforms think about BRNS?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is BRNS valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Barinthus Biotherapeutics PLC.

Explain Valuation
Alternatives to BRNS

Fundamental Analysis

Financials
Efficiency

Earnings Waterfall
Barinthus Biotherapeutics PLC

Wall St
Price Targets

Dividends

Barinthus Biotherapeutics PLC
does not pay dividends
Shareholder Yield

Competitive Landscape

What is the Intrinsic Value of one BRNS stock?

The intrinsic value of one BRNS stock under the Base Case scenario is 1.66 USD.

Is BRNS stock undervalued or overvalued?

Compared to the current market price of 0.61 USD, Barinthus Biotherapeutics PLC is Undervalued by 63%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett